Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Trauner, M; Baghdasaryan, A; Claudel, T; Fickert, P; Halilbasic, E; Moustafa, T; Zollner, G.
Targeting nuclear bile acid receptors for liver disease.
Dig Dis. 2011; 29(1):98-102
Doi: 10.1159/000324141
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Trauner Michael
- Co-Autor*innen der Med Uni Graz
-
Baghdasaryan Anna
-
Claudel Thierry
-
Fickert Peter
-
Halilbasic Emina
-
Moustafa Tarek
-
Zollner Gernot
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Bile acids (BAs) are able to activate a range of dedicated nuclear receptors (NRs) which play a key role in the transcriptional control of critical steps of a wide range of hepatic functions ranging from BA homeostasis and bile formation, phase I/II metabolism of endo- and xenobiotics such as BAs and drugs, respectively, to hepatic lipids and glucose metabolism. Apart from these metabolic roles, BA-activated nuclear receptors also play a key role in the control of hepatic inflammation, fibrogenesis, replication of hepatitis B and C virus, liver regeneration and carcinogenesis. As such, several physiological and pathophysiological effects of BAs can now be explained through activation of regulatory NR networks. Moreover, BA-activated NRs are key for understanding the pathogenesis of several liver diseases and represent attractive drug targets. This article will provide a brief overview on the role of BA-activated NRs in cholestatic and fatty liver disease.
Copyright © 2011 S. Karger AG, Basel.
- Find related publications in this database (using NLM MeSH Indexing)
-
Animals -
-
Bile Acids and Salts - metabolism
-
Cholestasis - metabolism
-
Homeostasis -
-
Humans -
-
Lipid Metabolism -
-
Liver Diseases - metabolism
-
Receptors, Cytoplasmic and Nuclear - metabolism
- Find related publications in this database (Keywords)
-
Bile acids
-
Nuclear receptors
-
Liver disease